The Oncology Institute, Inc. TOI Texas — Deferred tax asset, valuation allowance

Other geography segments

Similar metrics at other companies

GETYUNITED STATES — Deferred tax assets, valuation allowance

$194.5M+33.3%

BLMNU.S. — Deferred tax assets, valuation allowance

$1.4M+55.6%

BCUnited States — Deferred Tax Assets, Valuation Allowance

$54M-5.8%

MATVUnited States — Valuation allowance on deferred tax assets

$81.7M+85.7%

MTWUS — Deferred Tax Assets Valuation Allowance

$6.7M—

DNOWUS And Non US — Deferred Tax Assets Valuation Allowance

$88M+319%

Questions, answered.

What is The Oncology Institute, Inc.'s texas — deferred tax asset, valuation allowance?

The Oncology Institute, Inc. (TOI) reported texas — deferred tax asset, valuation allowance of $5K in Q4 2025.

What does texas — deferred tax asset, valuation allowance mean?

This metric represents the valuation allowance established against deferred tax assets specifically attributable to operations within the Texas geographic segment. It reflects management's assessment of the likelihood that the company will realize the tax benefits of these assets in future periods based on projected taxable income. A significant allowance indicates uncertainty regarding the recoverability of these tax benefits, which may impact the company's effective tax rate and overall financial position.